Galera Therapeutics Inc (GRTX)
0.1856
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
0.1973
+0.01
(+6.30%)
After-Hours: 07:56
Galera Therapeutics Total Assets (Quarterly): 19.65M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 19.65M |
December 31, 2023 | 26.14M |
September 30, 2023 | 37.78M |
June 30, 2023 | 48.28M |
March 31, 2023 | 59.71M |
December 31, 2022 | 44.04M |
September 30, 2022 | 50.71M |
June 30, 2022 | 61.08M |
March 31, 2022 | 71.10M |
December 31, 2021 | 83.31M |
September 30, 2021 | 98.76M |
Date | Value |
---|---|
June 30, 2021 | 115.27M |
March 31, 2021 | 70.49M |
December 31, 2020 | 84.10M |
September 30, 2020 | 98.08M |
June 30, 2020 | 114.30M |
March 31, 2020 | 130.81M |
December 31, 2019 | 123.38M |
September 30, 2019 | 79.76M |
June 30, 2019 | 91.04M |
December 31, 2018 | 88.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.65M
Minimum
Mar 2024
130.81M
Maximum
Mar 2020
75.39M
Average
75.43M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
iBio Inc | 50.15M |
Theriva Biologics Inc | 48.73M |
Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 154.34M |
Shareholders Equity (Quarterly) | -134.69M |